Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ambrx Biopharma Inc ADR
(NY:
AMAM
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, Mar 16, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ambrx Biopharma Inc ADR
< Previous
1
2
3
4
5
6
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 17, 2023
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Via
InvestorPlace
NetScout Systems, Ericsson And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
October 17, 2023
U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 16, 2023
Via
Benzinga
Cancer Focused Ambrx Biopharma Stock Trading Lower Today - Here's Why
October 16, 2023
Ambrx Biopharma Inc (NASDAQ: AMAM) announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic...
Via
Benzinga
Why Shares of Ambrx Biopharma Soared This Week
September 21, 2023
A big buy by an asset manager spurred interest in the biotech stock.
Via
The Motley Fool
Where Ambrx Biopharma Stands With Analysts
September 13, 2023
Via
Benzinga
Expert Ratings for Ambrx Biopharma
June 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 16, 2023
Via
Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Ambrx Biopharma
May 19, 2023
Via
Benzinga
Why Shares of Ambrx Biopharma Jumped This Week
May 18, 2023
The company reported data on its clinical programs at two conferences this week.
Via
The Motley Fool
Ambrx Biopharma Highlights Preclinical Data From Studies in Kidney, Prostate Cancer
April 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 16, 2023
Via
Benzinga
Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
October 16, 2023
Gainers LQR House Inc. (NASDAQ: LQR) shares surged 109% to $0.3602 in pre-market trading after the company delivered inaugural order to Costco, securing Von Payne Whiskey's presence on store shelves.
Via
Benzinga
Domino's, Walgreens, Fastenal And Other Big Stocks Moving Higher On Thursday
October 12, 2023
U.S. stocks traded mixed, with the Dow Jones falling around 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Around $19M Bet On Westrock Coffee? Check Out These 3 Stocks Insiders Are Buying
September 20, 2023
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 15, 2023
Via
Benzinga
PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday
September 15, 2023
U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
Ambrx Biopharma Has Surged 483% This Year. But It Could Just Be Getting Started.
August 31, 2023
The company has another update on its prostate cancer program that could further prod shares.
Via
Investor's Business Daily
Unique ADC Constructs Boost Ambrx Biopharma's Profile: Analyst Sees Optimistic Outlook
July 31, 2023
RBC Capital Markets initiated coverage on Ambrx Biopharma Inc (NASDAQ: AMAM) With an Outperform rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating
June 14, 2023
B Riley Securities has initiated Ambrx Biopharma Inc (NASDAQ: AMAM) with a Buy rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
June 02, 2023
Via
Benzinga
Ambrx Biopharma's Oncology Pipeline Is Underappreciated, Analyst Initiating Coverage Says
May 19, 2023
Cantor Fitzgerald initiated coverage on Ambrx Biopharma Inc (NASDAQ: AMAM) with an Overweight rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 19, 2023
May 19, 2023
Via
Benzinga
Why Sunrise New Energy Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
May 17, 2023
Gainers
Via
Benzinga
$59M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
April 21, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.